However, for FCN2 rs17514136, the frequency of the heterozygous AG genotype was significantly higher among LN patients (39.7%) compared with non-LN patients (24.2%) (OR, 2.06 [95% CI, 1.10–3.86]; P = 0.023), while the AA genotype was less frequent among LN patients (44.1% vs. 61.4%; OR, 0.50 [95% CI, 0.28 to 0.90]; P = 0.020). This evidence concerns the gene FCN2 and lobular neoplasia.